Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364423
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-04-12
Brief Title:
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Chronic Lymphocytic Leukemia CLL
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| B-Lymphocytic Leukemia Chronic |
| B-Cell Chronic Lymphocytic Leukemia |
| Leukemia Lymphocytic Chronic B-Cell |